Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 26;15(6):855.
doi: 10.3390/life15060855.

Predominant Gram-Positive Etiology May Be Associated with a Lower Mortality Rate but with Higher Antibiotic Resistance in Spontaneous Bacterial Peritonitis: A 7-Year Study in a Tertiary Center in Romania

Affiliations

Predominant Gram-Positive Etiology May Be Associated with a Lower Mortality Rate but with Higher Antibiotic Resistance in Spontaneous Bacterial Peritonitis: A 7-Year Study in a Tertiary Center in Romania

Sergiu Marian Cazacu et al. Life (Basel). .

Abstract

(1) Background: Spontaneous bacterial peritonitis (SBP) is associated with a 20% mortality and is mainly caused by Gram-negative bacteria (GNB); Gram-positive bacteria (GPB) were predominant in some areas; and increased antibiotic resistance was recorded. (2) Methods: A retrospective study was performed between 2018 and 2024. The type of isolated strains, antibiotic susceptibility, and mortality (in-hospital; 30-day; 90-day; and 1-year) were estimated; multivariate analyses evaluated predictive factors for in-hospital mortality risk. (3) Results: 45 culture-positive SBP, 28 culture-negative SBP, 6 bacterascites, and 670 control ascites were diagnosed; GPB represented 60%; two Candida peritonitis and 11 polymicrobial peritonitis (21.6%) were noted (without surgery; peritoneal dialysis; or tegumentary lesion). High resistance rates to cephalosporins and quinolones, and high carbapenem resistance for nosocomial GNB were recorded. A low resistance rate to Tigecycline was noted in all infection types; GPB was susceptible to Linezolid and Vancomycin; and GNB was susceptible to Aztreonam and Colistin. In-hospital mortality was 26.7% (40% for GNB-SBP; 20% for GPB-SBP), similar to culture-negative SBP (21.3%), and higher than in the control group (9%); long-term mortality remained higher. (4) Conclusions: microbial changes to GPB etiology and increasing resistance were noted, but with a lower mortality compared to GNB; higher mortality rates up to 1 year for culture-positive and culture-negative SBP were recorded.

Keywords: antibiotic susceptibility; gram-negative bacteria; gram-positive bacteria; spontaneous bacterial peritonitis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
The flowchart for patients enrolled in our study.
Figure 2
Figure 2
Temporal distribution for Gram-positive and Gram-negative strains during 2018–2024.
Figure 3
Figure 3
Antibiotic resistance in nosocomial and non-nosocomial ascitic fluid infection.
Figure 4
Figure 4
Antibiotic resistance in GPB ascitic fluid infection.
Figure 5
Figure 5
Antibiotic resistance in GNB ascitic fluid infection.
Figure 6
Figure 6
The distribution of the antibiotic resistance index among the Gram-negative identified strains.
Figure 7
Figure 7
Kaplan–Meier curve in culture-positive, culture-negative spontaneous bacterial peritonitis, and control patients.
Figure 8
Figure 8
Kaplan–Meier curve in Gram-positive and Gram-negative spontaneous bacterial peritonitis.

Similar articles

References

    1. European Association for the Study of the Liver EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J. Hepatol. 2018;69:406–460. doi: 10.1016/j.jhep.2018.03.024. Corrected in J. Hepatol. 2018, 69, 1207. https://doi.org/10.1016/j.jhep.2018.08.009 . - DOI - PubMed
    1. Biggins S.W., Angeli P., Garcia-Tsao G., Ginès P., Ling S.C., Nadim M.K., Wong F., Kim W.R. Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021;74:1014–1048. doi: 10.1002/hep.31884. - DOI - PubMed
    1. Ascione T., Di Flumeri G., Boccia G., De Caro F. Infections in patients affected by liver cirrhosis: An update. Infez. Med. 2017;25:91–97. - PubMed
    1. Piano S., Singh V., Caraceni P., Maiwall R., Alessandria C., Fernandez J., Soares E.C., Kim D.J., Kim S.E., Marino M., et al. International Club of Ascites Global Study Group. Epidemiology and Effects of Bacterial Infections in Patients with Cirrhosis Worldwide. Gastroenterology. 2019;156:1368–1380.E10. doi: 10.1053/j.gastro.2018.12.005. - DOI - PubMed
    1. Voicu M.N., Popescu F., Florescu D.N., Rogoveanu I., Turcu-Stiolica A., Gheonea D.I., Iovanescu V.F., Iordache S., Cazacu S.M., Ungureanu B.S. Clostridioides difficile Infection among Cirrhotic Patients with Variceal Bleeding. Antibiotics. 2021;10:731. doi: 10.3390/antibiotics10060731. - DOI - PMC - PubMed

LinkOut - more resources